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Clinical practice commonly demands ‘yes or no’ decisions;
and for this reason a clinician frequently needs to convert a
continuous diagnostic test into a dichotomous test. Receiver
operating characteristic (ROC) curve analysis is an important
test for assessing the diagnostic accuracy (or discrimination
performance) of quantitative tests throughout the whole
range of their possible values, and it helps to identify the
optimal cutoff value. The value of this analysis is not confined
to diagnosis in that it may also be applied to assess the
prognostic value of biomarkers and to compare their
predictive value. ROC curve analysis may also serve to
estimate the accuracy of multivariate risk scores aimed at
categorizing individuals as affected/unaffected by a given
disease/condition. However, one should be aware that, when
applied to prognostic questions, ROC curves don’t consider
time to event and right censoring, and may therefore
produce results that differ from those provided by classical
survival analysis techniques like Kaplan–Meier or Cox
regression analyses.
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In epidemiological research and in clinical medicine, the
measurement of specific markers of disease (like serum
creatinine or proteinuria) may serve different purposes like
screening, diagnosis, and prognosis. Discrimination perfor-
mance or accuracy, the ability of a given marker to correctly
classify individuals as having a specific disease/condition or
not, is a fundamental property of diagnostic and prognostic
markers. In a previous article of this series, we focused on
sensitivity, specificity, positive and negative predictive values
of qualitative tests, that is tests giving a result expressed
in dichotomic terms (presence/absence of the disease).1 In
this paper, we describe the assessment of the discrimination
performance of quantitative tests (tests providing a result
expressed in continuous or discrete terms) by the Receiver
Operating Characteristic (ROC) curve analysis. This analysis
estimates the accuracy of a quantitative test throughout
the complete range of its values and in this perspective it
is fundamental that the disease status is defined without
uncertainty, that is, by using a gold standard (or reference
standard). Furthermore, ROC curve analysis allows direct
comparison of the accuracy of two or more quantitative tests
for the same disease/condition and it may be used to assess
the accuracy of multiple logistic regression models aimed at
calculating the probability of a given individual as affected/
unaffected by a given disease/condition.
Example
John Nephron and co-workers, performed a survey in
65 randomly selected apparently healthy individuals taken
from the general population and in a sample of 184 conse-
cutive patients with renal dysfunction living in the area of
Glomerulonia (Kidneyland). Renal dysfunction was assessed
both by 24 h microalbuminuria (abnormal 430 mg/day) and
by measuring spot urine albumin to creatinine ratio (UACR).
The scope of the survey was that of assessing the accuracy of
UACR for identifying individuals with 24 h microalbuminur-
ia 430 mg/day. In healthy subjects, the median 24 h
microalbuminuria was 8 mg/day (Figure 1). The distribution
was asymmetrical (positively skewed distribution) and
the range of 24 h microalbuminuria went from 2 to 30 mg/day.
In patients with renal dysfunction (as defined by 24 h
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microalbuminuria) the median 24 h microalbuminuria was
40 mg/day and the range went from 31 to 60 mg/day. Because
of the way renal dysfunction was defined (that is, a 24 h
microalbuminuria 430 mg/day), there was no overlapping
between individuals with and without renal dysfunction.
In other words, in this study a 24 h microalbuminuria
430 mg/day perfectly discriminates sick and healthy people
(true-negative rate¼ 100%; true-positive rate: 100%; accu-
racy: 100%) (Figure 1).
Figure 2 shows that with UACR there is overlapping
between healthy individuals and patients with renal dysfunc-
tion indicating that this indicator does not perfectly discri-
minate the two groups. Indeed, by the 30 mg/g cutoff there is
a large proportion of healthy individuals and patients with
renal dysfunction correctly classified as disease-negative
(true-negative rate or specificity) and disease-positive (true-
positive rate or sensitivity), but also a proportion of healthy
individuals and patients with renal dysfunction incorrectly
classified as disease-positive and negative. Moving the cutoff
to the right (for example, to a UACR of 40 mg/g,) decreases
the false-positive rate (higher specificity) but also increases
the false-negative rate (lower sensitivity). Vice versa, moving
the cutoff point to the left (UACR¼ 20 mg/g) decreases the
false-negative rate (higher sensitivity) but also increases the
false-positive rate (lower specificity). Thus, the choice of the
cutoff critically affects the diagnostic performance of the test.
ROC curve analysis
Clinical practice commonly demands ‘yes or no’ decisions.
For this reason, we frequently need to convert a continuous
diagnostic test into a dichotomous test. In this vein,
we consider an individual as affected/unaffected by renal
dysfunction depending on whether he/she had a 24 h
microalbuminuria o or 430 mg/day. ROC curves analysis
assesses the discrimination performance of quantitative tests
throughout the whole range of their possible values and
helps to identify the optimal cutoff value.
An ROC curve is a graph plotting the combination of
sensitivity (true-positive rate) and the complement to
specificity (that is, 1-specificity, false-positive rate) across a
series of cutoff values covering the whole range of values of a
given disease marker. Because sensitivity and specificity are
both unaffected by the disease prevalence,1 also ROC curve
analysis and accuracy are also independent of the proportion
of the diseased. To construct an ROC curve for UACR, we
consider all possible UACR cutoffs throughout the whole
range of this measurement in patients and controls. By
plotting the pairs of sensitivity and 1-specificity correspond-
ing to each UACR cutoff, we obtain an ROC curve (Figure 3,
dotted line). A test with high discrimination has an ROC
curve approaching the upper left corner of the graph.
Therefore, the closer the ROC plot is to the upper left corner,
the higher the accuracy of the test. The closer the curve to the
diagonal line (also called reference line or chance line) of the
graph, the lower the accuracy of the test.
The overall discrimination performance of a given test is
measured by calculating the area under the ROC curve
(AUC). The AUC may be considered as a global estimate of
diagnostic accuracy. The AUC may take values ranging from
0.5 (no discrimination) to 1 (perfect discrimination). A
test has (at least some) discriminatory power if the 95%
confidence interval of the AUC does not include 0.50. In our
instance, the area under the ROC curve provided by UACR is
0.754 (95% CI: 0.681–0.826) (Figure 3, top panel), a figure
higher than that of diagnostic indifference (AUC: 0.50). An
area of 0.754 implies that in a hypothetical experiment in
which we randomly select pairs of healthy individuals and
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Figure 1 | Scattergram of 24 h microalbuminuria in patients
with renal dysfunction (gray circles) and in healthy subjects
(green circles). Because of the way we defined renal dysfunction,
there is no overlapping between individuals with and without the
disease, indicating that a 24 h microalbuminuria 430 mg/day
perfectly discriminates between sick and healthy people.
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Figure 2 | Scattergram of urine albumin:creatinine ratio
(UACR) in patients with renal dysfunction and in healthy
subjects. Because there is no perfect agreement between urine
albumin:creatinine ratio and 24 h microalbuminuria, a value of
UACR of 30 mg/g does not perfectly distinguish between sick and
healthy people. The standard UACR cutoff (30 mg/g) and the
additional UACR cutoffs (20 and 40 mg/g) are indicated by the
broken lines (see also text).
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patients with renal dysfunction, the test result (UACR)
will be higher (75.4% of times) in patients than in healthy
persons.
In principle, a test may not have an AUC lower than 0.5
unless a mistake is made in the analysis syntax. For example,
whether a diagnostic marker is lower in patients with the
disease than in those without the disease, the statistician has
to reverse the definition of ‘abnormal’ from a higher test
value to a lower test value by using a specific command
implemented in all statistical packages. This re-definition
eventually produces AUC greater than 0.50 and also in the
case of tests where lower rather than higher test results
identify diseased persons.
Choosing the cutoff value in the roc curve analysis
In the ROC curve analysis, the choice of the optimal cutoff
value depends both on probabilistic and clinical considera-
tions. From a probabilistic standpoint, if the weight of a
false-negative result is deemed comparable to that of a false-
positive result, one can use the coordinates of the ROC curve
to identify the UACR cutoff that maximizes the discrimina-
tion between true-positive rate and false-positive rate. In the
Glomerulonia example this value corresponds to 28 mg/g, a
threshold providing 73% sensitivity and 72% specificity
(Figure 3, bottom panel). On the other hand, because there
is concern that the prevalence of renal dysfunction by the
current classification is inflated,2 a clinician may be interested
in minimizing the false-positive rate. To this end, he may set
a fixed specificity (for example 95%, that implies 5% false-
positive rate) and on this basis identify in the ROC curve the
value of UACR providing this specificity (49 mg/g – Figure 3,
bottom panel). Otherwise, whether the interest of the clini-
cian is to maximize the identification of individuals with
renal dysfunction (for example when he wants to start an
aggressive reno-protective therapy) he needs to use a UACR
cutoff with high sensitivity. To this scope he may set a
fixed sensitivity (for example 95%) and identify the value
of UACR providing this sensitivity in the ROC curve
(15 mg/g – Figure 3, bottom panel).
ROC curve analysis and the accuracy of a predictive statistical
model
As described in a previous paper of this series,3 logistic
regression analysis describes the relationship between an
independent variable (either continuous or not) and a
dichotomic dependent variable, that is, a variable with only
two possible values: 0¼ disease absent and 1¼ disease
present. By using a multiple logistic regression model
(Table 1) it is possible to calculate not only the odds ratio
associated with covariates included in the model, but also to
estimate the individual probability of the disease (see below).
As shown in Table 1 both UACR and age are indepen-
dently associated with renal dysfunction. Indeed, 1 mg/g
increase in UACR underlies a 5% increase in the odds of renal
dysfunction (odds ratio¼ 1.05) and a 1-year increase in age
increases the odds for the same condition by 4% (odds
ratio¼ 1.04).
By using the regression coefficients of the two covariates in
the logistic model (UACR and age) and the constant of the
same model (Table 1) we can calculate the individual
probability (P) or score of renal dysfunction by the formula:
P ¼ exp
b0þb1UACRþb2Age
1þ expb0þb1UACRþb2Age
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ROC curve analysis for renal dysfunction
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Figure 3 | ROC curves. Top panel: ROC curve analysis of urine
albumin:creatinine ratio (UACR) alone (dotted line) and of a
logistic model including both UACR and age (continuous line) for
the diagnosis of renal dysfunction. Bottom panel: UACR ROC
curve. The figures over the curve correspond to a series of UACR
values used to generate the same curve. The green arrow
identifies the ‘best probabilistic cutoff’ and the black arrows the
cutoffs identifying the UACR values corresponding to 95%
specificity and 95% sensitivity, respectively.
Table 1 | Multiple logistic regression model for renal
dysfunction
Units of
increase
Regression
coefficient
Odds ratio
and 95% CI P-value
UACR 1 mg/g 0.0528 1.05 (1.02–1.09) o0.001
Age 1 year 0.0393 1.04 (1.02–1.06) o0.001
Dependent variable: renal dysfunction.
Constant =2.5032.
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where:
P= individual probability (score) of renal dysfunction
b0 (constant)= 2.5032
b1 (regression coefficient of UACR)= 0.0528
b2 (regression coefficient of age)= 0.0393
Because this probability or score is a measure of the
propensity of each individual be affected or unaffected by
renal dysfunction, we can test its accuracy by ROC curve
analysis (Figure 3– left panel, continuous line). As shown in
Figure 3, a logistic model including UACR and age provides
an AUC of 0.789 (Figure 3 – left panel), a figure 3.5% higher
than that provided by UACR alone (AUC:0.754) indicating
that age improves the accuracy of the classification of renal
dysfunction based on UACR.
ROC curve analysis and prognostic markers
In clinical practice, we use diagnostic markers to test whether
the individual who underwent the test is affected or
unaffected by a specific disease at a given point in time. In
this perspective, all diagnostic questions are ‘prevalent
questions’. When we deal with prognosis, we may use a
biomarker to predict the disease outcome. However, here we
need to consider the temporal dimension of the course of the
disease, that is, the time to the occurrence of the event we
want to prognosticate. Time to event analysis by the
Kaplan–Meier and the Cox proportional hazard methods4,5
provide individual estimates of the probability of a given
outcome in a given point in time. Even though ROC curve
analysis is frequently used to test the prognostic value of
biomarkers and risk factors in general, the fact that it does
not take into account the time to an event or right censoring
should not be overlooked. Indeed, it may happen that a given
risk factor predicts the time to event by survival analysis
testing but that it has no discriminatory power when tested
by an ROC curve analysis and vice versa. When a risk factor
predicts both the occurrence of the event and the time
to event or when time to event is not so important, ROC
curve analysis may be used to compare the predictive value
of different prognostic markers. In a paper by Tripepi G
et al.6 the prognostic value of night/day systolic ratio was
investigated in a cohort of 168 non-diabetic, events-free
hemodialysis patients. This ratio resulted to be an indepen-
dent predictor of all-cause and cardiovascular mortality and
patients with a ratio 41.01 had a risk of death and CV
outcomes that was three to five times higher than those with
a ratio o0.93 in a Cox model adjusting for age, smoking,
cholesterol, and left ventricular hypertrophy (LVH). To
compare the value of night/day systolic ratio for all-cause
and cardiovascular mortality with that of LVH for the same
outcomes the authors used ROC curve analysis. By this
approach, the night/day systolic ratio and LVH had very close
predictive power (see Figure 4) indicating that the prognostic
value of night/day systolic ratio and of LVH were substan-
tially similar. The authors also estimated the gain in predic-
tion power which could be obtained by jointly considering
the two risk factors and found that it was of modest degree
(þ 5% both for all-cause and CV mortality) (Figure 4)
thus concluding that the night/day systolic ratio and LVH
provide overlapping prognostic information, a phenomenon
in keeping with the hypothesis that they are in the same
pathway leading to adverse outcomes in ESRD.
Conclusions
ROC curve analysis is an important statistical tool to
investigate the accuracy of a quantitative test throughout
the whole range of its values and to help to identify the
optimal cutoff value. This analysis may also be applied to
assess the accuracy of a multiple logistic regression model
aimed at categorizing individuals as having or not having a
given disease. ROC curves are also used to test the prognostic
value of biomarkers and to compare their predictive value.
However, we should be aware that ROC curve analysis only
considers the occurrence of events and not time to event. In
addition, it does not consider right censoring and it may
therefore produce results that differ from those provided by
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Figure 4 | ROC curve analysis of the night/day systolic ratio
and LVH for all-cause and CV mortality (see text and Tripepi
et al.6 for more details).
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classical survival analysis techniques like Kaplan–Meier or
Cox regression analyses.
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